APTEKA 100+, OOO, Rostov Oblast

Economic indicators

Net profit (RAS) of APTEKA 100+, OOO made up 1.70 million RUB over 2023 compared to net loss of 83.00 thousand RUB over 2022, the company informed.

Revenue decreased in the accounting period 2.89 times to 3.27 million RUB from 9.42 million RUB in 2022; cost of goods sold decreased 2.65 times to 2.85 million RUB from 7.57 million RUB; sales loss made up 255.00 thousand RUB compared to sales profit of 134.00 thousand RUB.

Net loss (RAS) of APTEKA 100+, OOO dropped over 2022 13.20 times to 83.00 thousand RUB from 1.10 million RUB KAgent.Entities.Balance, the company informed.

Revenue decreased in the accounting period by 20.32% to 9.42 million RUB from 11.83 million RUB in 2021; cost of goods sold decreased by 21.66% to 7.57 million RUB from 9.66 million RUB; sales profit made up 134.00 thousand RUB compared to sales loss of 703.00 thousand RUB.

Net loss (RAS) of APTEKA 100+, OOO increased 6.45 times to 1.10 million RUB from 170.00 thousand RUB over 2020, the company informed.

Revenue decreased in the accounting period by 10.57% to 11.83 million RUB from 13.22 million RUB in 2020; cost of goods sold decreased by 12.94% to 9.66 million RUB from 11.09 million RUB; sales loss grew 21.30 times to 703.00 thousand RUB from 33.00 thousand RUB.

Net loss (RAS) of APTEKA 100+, OOO dropped over 2020 2.14 times to 170.00 thousand RUB from 364.00 thousand RUB KAgent.Entities.Balance, the company informed.

Revenue increased in the accounting period 1.94 times to 13.22 million RUB from 6.82 million RUB over 2019; cost of goods sold grew 1.90 times to 11.09 million RUB from 5.84 million RUB; sales loss decreased 7.55 times to 33.00 thousand RUB from 249.00 thousand RUB.

Companies in the region

• PSS
• CHISTYULYA
• MEDPROFDIAGNOSTIKA
• RADIAL
• TRAST